Relationship between Atherogenic Indices and Carotid Intima-Media Thickness in Prediabetes: A Cross-Sectional Study from Central India
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Design and Inclusion Criteria
- (a)
- Fasting plasma glucose level 100–125 mg/dL (Impaired fasting glucose, IFG), and
- (b)
- 2-h plasma glucose (after giving 75 g of glucose) level 140–199 mg/dL (Impaired glucose tolerance, IGT) [17].
2.2. Exclusion Criteria
2.3. Anthropometric Measurements
2.4. Blood Pressure Measurements
2.5. Measurement of Carotid Intima Media Tthickness
2.6. Biochemical Measurements
2.7. Statistical Analysis
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
References
- Deedwania, P.C.; Fonseca, V.A. Diabetes, prediabetes and cardiovascular risk: Shifting the paradigm. Am. J. Med. 2005, 118, 939–947. [Google Scholar] [CrossRef] [PubMed]
- Ford, E.S.; Zhao, G.; Li, C. Pre-diabetes and the risk for cardiovascular disease: A systematic review of the evidence. J. Am. Coll. Cardiol. 2010, 55, 1310–1317. [Google Scholar] [CrossRef] [PubMed]
- Tabak, A.G.; Herder, C.; Rathmann, W.; Brunner, E.J.; Kivimaki, M. Prediabetes: A high-risk state for diabetes development. Lancet 2012, 379, 2279–2290. [Google Scholar] [CrossRef]
- International Diabetes Federation. IDF Diabetes Atlas, 7th ed.; International Diabetes Federation: Brussels, Belgium, 2015. [Google Scholar]
- Anjana, R.M.; Deepa, M.; Pradeepa, R.; Mahanta, J.; Narain, K.; Das, H.K.; Adhikari, P.; Rao, P.V.; Saboo, B.; Kumar, A.; et al. Prevalence of diabetes and prediabetes in 15 states of India: Results from the ICMR-INDIAB population-based cross-sectional study. Lancet Diabetes Endocrinol. 2017, 5, 585–596. [Google Scholar] [CrossRef]
- Grundy, S.M. Pre-diabetes, metabolic syndrome, and cardiovascular risk. J. Am. Coll. Cardiol. 2012, 59, 635–643. [Google Scholar] [CrossRef] [PubMed]
- Kansal, S.; Kamble, T.K. Lipid profile in prediabetes. J. Assoc. Physicians India 2016, 64, 18–21. [Google Scholar] [PubMed]
- Balgi, V.; Harshavardan, L.; Sahna, E.; Thomas, S.K. Pattern of lipid profile abnormality in subjects with prediabetes. Int. J. Sci. Study 2017, 4, 150–153. [Google Scholar]
- Millan, J.; Pinto, X.; Munoz, A.; Zuniga, M.; Rubies-Prat, J.; Pallardo, L.F.; Masana, L.; Mangas, A.; Hernández-Mijares, A.; González-Santos, P.; et al. Lipoprotein ratios: Physiological significance and clinical usefulness in cardiovascular prevention. Vasc. Health Risk Manag. 2009, 5, 757–765. [Google Scholar] [PubMed]
- Bafna, A.; Maheshwari, R.S.; Ved, R.K.; Sarkar, P.D.; Batham, A.R. Study of atherogenic indices in nephrotic syndrome. Int. J. Biol. Med. Res. 2012, 3, 2257–2260. [Google Scholar]
- Deric, M.; Kojic-Damjanov, S.; Cabarkapa, V.; Eremic, N. Biochemical Markers of Atherosclerosis. JMB 2008, 27, 148–153. [Google Scholar]
- Onat, A. Lipids, lipoproteins and apolipoproteins among Turks, and impact on coronary heart disease. Anadolu Kardiyol. Derg. 2004, 4, 236–245. [Google Scholar] [PubMed]
- Liu, T.; Meng, X.Y.; Li, T.; Zhang, D.Y.; Zhou, Y.H.; Han, Q.F.; Wang, L.H.; Wu, L.; Yao, H.C. Rosuvastatin may stabilize vulnerable carotid plaques and reduce carotid intima media thickness in patients with hyperlipidemia. Int. J. Cardiol. 2016, 212, 20–21. [Google Scholar] [CrossRef] [PubMed]
- Hemerich, D.; van der Laan, S.W.; Tragante, V.; den Ruijter, H.M.; de Borst, G.J.; Pasterkamp, G.; de Bakker, P.I.; Asselbergs, F.W. Impact of carotid atherosclerosis loci on cardiovascular events. Atherosclerosis 2015, 243, 466–468. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Cure, M.C.; Tufekci, A.; Cure, E.; Kirbas, S.; Ogullar, S.; Kirbas, A.; Unal, H.; Yuce, S.; Cakmak, S. Low-density lipoprotein subfraction, carotid artery intima-media thickness, nitric oxide, and tumor necrosis factor alpha are associated with newly diagnosed ischemic stroke. Ann. Indian Acad. Neurol. 2013, 16, 498–503. [Google Scholar] [CrossRef] [PubMed]
- Mookadam, F.; Moustafa, S.E.; Lester, S.J.; Warsame, T. Subclinical atherosclerosis: Evolving the role of carotid intima-media thickness. Prev. Cardiol. 2010, 13, 186–197. [Google Scholar] [CrossRef] [PubMed]
- American Diabetes Association. Classification and diagnosis of diabetes. Sec. 2. In Standards of Medical Care in Diabetes-2017. Diabetes Care 2017, 40, S11–S24. [Google Scholar]
- Mahat, R.K.; Singh, N.; Gupta, A.; Rathore, V. Oxidative DNA damage and carotid intima media thickness as predictors of cardiovascular disease in prediabetic subjects. J. Cardiovasc. Dev. Dis. 2018, 5, 15. [Google Scholar] [CrossRef] [PubMed]
- Friedewald, W.T.; Levy, R.I.; Fredrickson, D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 1972, 18, 499–502. [Google Scholar] [PubMed]
- Huang, S.; Peng, W.; Zhao, W.; Sun, B.; Jiang, X. Higher plasma C-reactive protein and lower plasma adiponectin are associated with increased carotid artery intima-media thickness in patients with impaired glucose regulation. Asian Biomed. 2017, 7, 399–405. [Google Scholar]
- Yang, C.; Sun, Z.; Li, Y.; Ai, J.; Sun, Q.; Tian, Y. The correlation between serum lipid profile with carotid intima-media thickness and plaque. BMC Cardiovasc. Disord. 2014, 14, 181. [Google Scholar] [CrossRef] [PubMed]
- Nakamura, H.; Arakawa, K.; Itakura, H.; Kitabatake, A.; Goto, Y.; Toyota, T.; Nakaya, N.; Nishimoto, S.; Muranaka, M.; Yamamoto, A.; et al. Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): A prospective randomised controlled trial. Lancet 2006, 368, 1155–1163. [Google Scholar] [CrossRef]
- Cannon, C.P.; Braunwald, E.; McCabe, C.H.; Rader, D.J.; Rouleau, J.L.; Belder, R.; Joyal, S.V.; Hill, K.A.; Pfeffer, M.A.; Skene, A.M.; et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N. Engl. J. Med. 2004, 350, 1495–1504. [Google Scholar] [CrossRef] [PubMed]
- Gholi, Z.; Heidari-Beni, M.; Feizi, A.; Iraj, B.; Askari, G. The characteristics of pre-diabetic patients associated with body composition and cardiovascular disease risk factors in the Iranian population. J. Res. Med. Sci. 2016, 21, 20. [Google Scholar] [PubMed]
- Boden, G.; Laakso, M. Lipids and glucose in type 2 diabetes: What is the cause and effect? Diabetes Care 2004, 27, 2253–2259. [Google Scholar] [CrossRef] [PubMed]
- McGarry, J.D. Banting lecture 2001: Dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 2002, 51, 7–18. [Google Scholar] [CrossRef] [PubMed]
- Boizel, R.; Benhamou, P.Y.; Lardy, B.; Laporte, F.; Foulon, T.; Halimi, S. Ratio of triglycerides to HDL cholesterol is an indicator of LDL particle size in patients with type 2 diabetes and normal HDL cholesterol levels. Diabetes Care 2000, 23, 1679–1685. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Gaal, K.; Tarr, T.; Lorincz, H.; Borbas, V.; Seres, I.; Harangi, M.; Fülöp, P.; Paragh, G. High-density lipopoprotein antioxidant capacity, subpopulation distribution and paraoxonase-1 activity in patients with systemic lupus erythematosus. Lipids Health Dis. 2016, 15, 60. [Google Scholar] [CrossRef] [PubMed]
- Krauss, R.M. Lipids and lipoproteins in patients with type 2 diabetes. Diabetes Care 2004, 27, 1496–1504. [Google Scholar] [CrossRef] [PubMed]
- Rosvall, M.; Persson, M.; Östling, G.; Nilsson, P.M.; Melander, O.; Hedblad, B.; Engström, G. Risk factors for the progression of carotid intima-media thickness over a 16-year follow-up period: The Malmö Diet and Cancer Study. Atherosclerosis 2015, 239, 615–621. [Google Scholar] [CrossRef] [PubMed]
- Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Circulation 2002, 106, 3143–3421.
- Singh, M.; Pathak, M.S.; Paul, A. A study on atherogenic indices of pregnancy induced hypertension patients as compared to normal pregnant women. J. Clin. Diagn. Res. 2015, 9, BC05–BC08. [Google Scholar] [CrossRef] [PubMed]
- Onat, A.; Can, G.; Kaya, H.; Hergenc, G. “Atherogenic index of plasma” (log10 triglyceride/high-density lipoprotein-cholesterol) predicts high blood pressure, diabetes, and vascular events. J. Clin. Lipidol. 2010, 4, 89–98. [Google Scholar] [CrossRef] [PubMed]
- Dobiasova, M. Atherogenic index of plasma [log(triglycerides/HDL-cholesterol)]: Theoretical and practical implications. Clin. Chem. 2004, 50, 1113–1115. [Google Scholar] [CrossRef] [PubMed]
- Dobiasova, M.; Frohlich, J. The plasma parameter log (TG/HDL-C) as an atherogenic index: Correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FERHDL). Clin. Biochem. 2001, 34, 583–588. [Google Scholar] [CrossRef]
- Dobiasova, M. AIP-atherogenic index of plasma as a significant predictor of cardiovascular risk: From research to practice. Vnitr. Lek. 2006, 52, 64–71. [Google Scholar] [PubMed]
- Regmi, P.; Baral, B.; Raut, M.; Khanal, M.P. Atherogenic index of plasma for prediction of future cardiovascular disease in prediabetes and diabetes population. Atherosclerosis 2016, 252, e120. [Google Scholar] [CrossRef]
- Thiyagarajan, R.; Subramanian, S.K.; Sampath, N.; Trakroo, M.; Pal, P.; Bobby, Z.; Paneerselvam, S.; Das, A.K. Association between cardiac autonomic function, oxidative stress and inflammatory response in impaired fasting glucose subjects: Cross-sectional study. PLoS ONE 2012, 7, e41889. [Google Scholar] [CrossRef] [PubMed]
- O'Leary, D.H.; Polak, J.F.; Kronmal, R.A.; Manolio, T.A.; Burke, G.L.; Wolfson, S.K., Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N. Engl. J. Med. 1999, 340, 14–22. [Google Scholar] [CrossRef] [PubMed]
- Lorenz, M.W.; Markus, H.S.; Bots, M.L.; Rosvall, M.; Sitzer, M. Prediction of clinical cardiovascular events with carotid intima-media thickness: A systematic review and meta-analysis. Circulation 2007, 115, 459–467. [Google Scholar] [CrossRef] [PubMed]
- Icli, A.; Cure, E.; Cure, M.C.; Uslu, A.U.; Balta, S.; Mikhailidis, D.P.; Ozturk, C.; Arslan, S.; Sakız, D.; Sahin, M.; et al. Endocan levels and subclinical atherosclerosis in patients with systemic lupus erythematosus. Angiology 2016, 67, 749–755. [Google Scholar] [CrossRef] [PubMed]
- Altin, C.; Sade, L.E.; Gezmis, E.; Ozen, N.; Duzceker, O.; Bozbas, H.; Eroglu, S.; Muderrisoglu, H. Assessment of subclinical atherosclerosis by carotid intima-media thickness and epicardial adipose tissue thickness in prediabetes. Angiology 2016, 67, 961–969. [Google Scholar] [CrossRef] [PubMed]
- Karbek, B.; Cakal, E.; Cakir, E.; Bozkurt, N.; Unsal, I.; Sahin, M.; Delibasi, T. Cardiovascular risk factors, carotid artery intima media thickness, and HSCRP levels in patients with impaired glucose metabolism. Minerva Endocrinol. 2013, 38, 297–304. [Google Scholar] [PubMed]
- Aydin, Y.; Berker, D.; Ustün, I.; Gül, K.; Erden, G.; Kutlucan, A.; Yilmaz Aydin, L.; Güler, S. Evaluation of carotid intimamedia thickness in impaired fasting glucose and impaired glucose tolerance. Minerva Endocrinol. 2011, 36, 171–179. [Google Scholar] [PubMed]
- Touboul, P.J.; Grobbee, D.E.; den Ruijter, H. Assessment of subclinical atherosclerosis by carotid intima media thickness: Technical issues. Eur. J. Prev. Cardiol. 2012, 19, 18–24. [Google Scholar] [CrossRef] [PubMed]
- Yildiz, G.; Duman, A.; Aydin, H.; Yilmaz, A.; Hür, E.; Mağden, K.; Cetin, G.; Candan, F. Evaluation of association between atherogenic index of plasma and intima-media thickness of the carotid artery for subclinic atherosclerosis in patients on maintenance hemodialysis. Hemodial. Int. 2013, 17, 397–405. [Google Scholar] [CrossRef] [PubMed]
- Cure, E.; Icli, A.; Ugur Uslu, A.; Aydoğan Baykara, R.; Sakiz, D.; Ozucan, M.; Yavuz, F.; Arslan, S.; Cumhur Cure, M.; Kucuk, A. Atherogenic index of plasma may be strong predictor of subclinical atherosclerosis in patients with Behçet disease. Z. Rheumatol. 2017, 76, 259–266. [Google Scholar] [CrossRef] [PubMed]
- Uslu, A.U.; Kucuk, A.; Icli, A.; Cure, E.; Sakiz, D.; Arslan, S.; Baykara, R.A. Plasma atherogenic index is an independent indicator of subclinical atherosclerosis in systemic lupus erythematosus. Eurasian J. Med. 2017, 49, 193–197. [Google Scholar] [CrossRef] [PubMed]
- Icli, A.; Cure, E.; Uslu, A.U.; Sakiz, D.; Cure, M.C.; Ozucan, M.; Baykara, R.A.; Karakoyun, A.; Balta, S.; Ozturk, C.; et al. The relationship between atherogenic index and carotid artery atherosclerosis in familial mediterranean fever: A pilot study. Angiology 2017, 68, 315–321. [Google Scholar] [CrossRef] [PubMed]
Variables | Control Subjects (n = 200) | Prediabetic Subjects (n = 200) |
---|---|---|
Age (years) | 39.07 ± 7.60 | 39.90 ± 8.84 NS |
Sex (M/F) | 112/88 | 106/94 NS |
BMI (kg/m2) | 23.42 ± 0.94 | 29.08 ± 1.66 ** |
WC (cm) | 82.51 ± 2.82 | 92.02 ± 3.91 ** |
HC (cm) | 95.42 ± 2.42 | 95.99 ± 2.61 * |
WHR | 0.86 ± 0.03 | 0.96 ± 0.03 ** |
SBP (mmHg) | 116.30 ± 3.31 | 127.00 ± 5.66 ** |
DBP (mmHg) | 77.48 ± 3.36 | 81.87 ± 3.63 ** |
FPG (mg/dL) | 90.19 ± 3.83 | 116.13 ± 3.62 ** |
2-h PG (mg/dL) | 123.65 ± 6.20 | 150.13 ± 4.16 ** |
TC (mg/dL) | 180.19 ± 14.33 | 190.67 ± 18.44 ** |
TG (mg/dL) | 120.70 ± 19.84 | 148.19 ± 18.80 ** |
HDL (mg/dL) | 42.86 ± 3.40 | 32.81 ± 2.79 ** |
LDL (mg/dL) | 113.20 ± 14.47 | 128.22 ± 18.60 ** |
VLDL (mg/dL) | 24.14 ± 3.97 | 29.64 ± 3.76 ** |
Variables | AIP | CRR | AC | CIMT |
---|---|---|---|---|
Age | 0.378 ** | 0.422 ** | 0.422 ** | 0.419 ** |
BMI | 0.385 ** | 0.426 ** | 0.426 ** | 0.340 ** |
WHR | 0.236 ** | 0.251 ** | 0.251 ** | 0.242 ** |
SBP | 0.369 ** | 0.365 ** | 0.365 ** | 0.441 ** |
DBP | 0.311 ** | 0.392 ** | 0.392 ** | 0.244 ** |
FPG | 0.607 ** | 0.636 ** | 0.636 ** | 0.559 ** |
2-h PG | 0.569 ** | 0.590 ** | 0.590 ** | 0.653 ** |
TC | 0.340 ** | 0.825 ** | 0.825 ** | 0.395 ** |
HDL | −0.682 ** | −0.755 ** | −0.755 ** | −0.385 ** |
TG | 0.878 ** | 0.341 ** | 0.341 ** | 0.449 ** |
LDL | 0.261 ** | 0.862 ** | 0.862 ** | 0.359 ** |
VLDL | 0.878 ** | 0.341 ** | 0.341 ** | 0.449 ** |
Variables | AIP | CRR | AC | CIMT |
---|---|---|---|---|
Age | 0.003 NS | 0.084 NS | 0.083 NS | 0.325 ** |
BMI | 0.138 NS | 0.108 NS | 0.108 NS | −0.004 NS |
WHR | 0.050 NS | 0.011 NS | 0.011 NS | 0.006 NS |
SBP | 0.092 NS | 0.052 NS | 0.053 NS | −0.009 NS |
DBP | −0.015 NS | 0.127 NS | 0.127 NS | 0.053 NS |
FPG | 0.092 NS | 0.112 NS | 0.112 NS | 0.116 NS |
2-h PG | 0.081 NS | 0.051 NS | 0.051 NS | 0.049 NS |
TC | 0.150 * | 0.712 ** | 0.712 ** | 0.050 NS |
HDL | −0.542 ** | −0.711 ** | −0.711 ** | −0.068 NS |
TG | 0.917 ** | 0.254 ** | 0.255 ** | 0.059 NS |
LDL | 0.024 NS | 0.802 ** | 0.802 ** | 0.050 NS |
VLDL | 0.917 ** | 0.254 ** | 0.255 ** | 0.059 NS |
Variables | CIMT | |
---|---|---|
Prediabetic Subjects | Control Subjects | |
AIP | 0.529 ** | 0.075 NS |
CRR | 0.495 ** | 0.081 NS |
AC | 0.495 ** | 0.081 NS |
© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Mahat, R.K.; Singh, N.; Rathore, V.; Gupta, A.; Shah, R.K. Relationship between Atherogenic Indices and Carotid Intima-Media Thickness in Prediabetes: A Cross-Sectional Study from Central India. Med. Sci. 2018, 6, 55. https://doi.org/10.3390/medsci6030055
Mahat RK, Singh N, Rathore V, Gupta A, Shah RK. Relationship between Atherogenic Indices and Carotid Intima-Media Thickness in Prediabetes: A Cross-Sectional Study from Central India. Medical Sciences. 2018; 6(3):55. https://doi.org/10.3390/medsci6030055
Chicago/Turabian StyleMahat, Roshan Kumar, Neelima Singh, Vedika Rathore, Akshara Gupta, and Rakesh Kumar Shah. 2018. "Relationship between Atherogenic Indices and Carotid Intima-Media Thickness in Prediabetes: A Cross-Sectional Study from Central India" Medical Sciences 6, no. 3: 55. https://doi.org/10.3390/medsci6030055
APA StyleMahat, R. K., Singh, N., Rathore, V., Gupta, A., & Shah, R. K. (2018). Relationship between Atherogenic Indices and Carotid Intima-Media Thickness in Prediabetes: A Cross-Sectional Study from Central India. Medical Sciences, 6(3), 55. https://doi.org/10.3390/medsci6030055